"complete by Q2" I interpret that as complete by the start not complete by the end. Obviously wishful thinking on my part haha Sadly its written rather vague. Clearly its on track to be complete by the end of Q2. Anyway James has blown out all prior estimates by a year plus. Just go back to the end of 2020 and read the announcement "Business update" from December 16. Add in fat to any future timelines to avoid disappointment
Ann: Positive safety data from 4th Cohort -Phase I Clinical Trial, page-7
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
53.5¢ |
Change
0.015(2.88%) |
Mkt cap ! $124.0M | |||
| Open | High | Low | Value | Volume |
| 53.0¢ | 54.0¢ | 52.0¢ | $17.89K | 33.76K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 61295 | 52.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 53.5¢ | 37072 | 1 |
View Market Depth
| Last trade - 16.10pm 08/10/2024 (20 minute delay) ? |
| RCE (ASX) Chart |